Brucellosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 11: | Line 11: | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Pulmonology]] | |||
[[Category:Hepatology]] | |||
[[Category:Rheumatology]] | |||
[[Category:Nephrology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Infectious disease]] | |||
Latest revision as of 20:45, 29 July 2020
|
Brucellosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Brucellosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Brucellosis secondary prevention |
|
Risk calculators and risk factors for Brucellosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]
Overview
Secondary prevention strategies of Brucellosis include follow up of the patient upto 2 years following the diagnosis of Brucellosis to monitor for relapse.
Secondary prevention
Secondary prevention strategies of Brucellosis include follow up of the patient upto 2 years following the diagnosis of Brucellosis to monitor for relapse and chronic brucellosis.[1]
Reference
- ↑ Brucellosis "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 9th, 2017